Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
Global cell harvesting system market was valued at USD 3,839 million in 2024. The market is projected to grow from USD 4,180 million in 2025 to USD 6,720 million by 2031, exhibiting a CAGR of 8.5% during the forecast period.
Cell harvesting systems are critical laboratory instruments used for isolating cells from culture media or tissues, primarily for applications in biopharmaceutical research and therapy development. These systems include both manual and automated solutions, with automated harvesters gaining prominence due to higher efficiency in large-scale cell processing. The technology is particularly vital for stem cell harvesting from blood or bone marrow - a cornerstone of modern regenerative medicine.
The market growth is being propelled by robust investments in cell-based therapies, particularly in oncology and autoimmune disease treatment. While North America currently dominates the market with over 40% revenue share due to advanced medical infrastructure, Asia-Pacific is emerging as the fastest-growing region with a projected CAGR of 9.8% through 2031. Key players like PerkinElmer and Terumo BCT are actively expanding their automated harvesting solutions to meet the surge in demand from pharmaceutical companies and research institutions.
Increasing Demand for Regenerative Medicine
The global cell harvesting systems market is experiencing significant growth driven by the rising demand for regenerative medicine. The increasing prevalence of chronic diseases and the need for advanced therapies have propelled the adoption of cell-based treatments, with the market projected to grow at a CAGR of 8.2% over the next five years.
Technological Advancements in Harvesting Systems
Recent technological innovations in automated cell harvesting systems have improved efficiency and reduced contamination risks. Manufacturers are focusing on developing closed-system solutions that minimize human intervention, with automated systems now accounting for over 45% of total market revenue.
Key opinion leaders report that automated cell harvesting can increase yield by up to 30% compared to manual methods
The growing biotechnology and pharmaceutical R&D investments, currently exceeding $180 billion annually worldwide, are further accelerating market expansion as companies seek more efficient cell processing solutions.
MARKET CHALLENGES
High Equipment Costs and Implementation Barriers
The capital-intensive nature of advanced cell harvesting systems presents a significant challenge, with prices ranging from $50,000 to $250,000 per unit. This creates adoption barriers for smaller research facilities and hospitals in developing regions.
Other Challenges
Regulatory Compliance Complexity
Stringent FDA and EMA regulations for cell-based products require extensive validation processes, with approval timelines often exceeding 18 months for new harvesting technologies.
Shortage of Skilled Professionals
The market faces constraints due to the limited availability of trained technicians capable of operating advanced cell harvesting systems. Current estimates suggest a global deficit of over 20,000 qualified personnel in this specialized field.
Expansion in Emerging Markets
Asia-Pacific represents the fastest-growing regional market, with projected growth of 11.4% CAGR, driven by increasing healthcare expenditure and government support for biotechnology infrastructure development in countries like China and India.
Personalized Medicine Applications
The rising focus on personalized cell therapies creates new opportunities, with the CAR-T cell therapy segment alone expected to drive $1.2 billion in harvesting system sales by 2027.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Automated Cell Harvesters are gaining significant traction due to their precision and efficiency in cell collection processes. The market shows strong preference for automation to minimize human error and improve reproducibility in sensitive cell harvesting applications, particularly in research and clinical settings. |
| By Application |
|
Stem Cell Research dominates application segments due to increasing investments in regenerative medicine. The growing pipeline of cell therapies and government funding for stem cell research are creating substantial demand for advanced cell harvesting systems capable of maintaining cell viability and purity. |
| By End User |
|
Biopharmaceutical Companies represent the most demanding end-users as they scale up cell therapy production. These companies require high-throughput harvesting solutions that integrate seamlessly with other bioprocessing equipment while meeting stringent regulatory requirements for therapeutic cell products. |
| By Technology |
|
Centrifugation-based technology remains the industry standard due to its proven reliability and wide adoption. However, microfluidic-based systems are emerging as a disruptive alternative, offering gentler cell processing that maintains higher viability rates for delicate cell types used in advanced therapies. |
| By Scale |
|
Clinical-scale harvesting systems are witnessing rapid adoption as cell therapies progress through clinical trials. The market shows increasing demand for systems that can bridge the gap between research and commercial production, offering scalability while maintaining process consistency and product quality. |
Innovation and Strategic Partnerships Drive Market Growth
The cell harvesting system market is dominated by established biomedical equipment manufacturers, with PerkinElmer and Terumo BCT leading in market share. These companies have strengthened their positions through continuous R&D investments and strategic acquisitions of niche technology providers. The market exhibits moderate consolidation with top 5 players accounting for over 45% of global revenues in 2024.
Emerging players like Scinomix and ADS Biotec are gaining traction through specialized automated harvesting solutions for stem cell research. Regional leaders such as Sartorius in Europe and Tomtec in North America maintain strong distribution networks while developing application-specific harvesting technologies.
List of Key Cell Harvesting System Companies ProfiledPerkinElmer
COX Scientific
Connectorate
Tomtec
ADS Biotec
General Electric
BioVision
MagLife Sciences
STEMCELL Technologies
Argos Technologies
The global cell harvesting system market is experiencing robust growth, with valuations reaching $3839 million in 2024 and projected to hit $6720 million by 2031, growing at an 8.5% CAGR. This expansion is primarily driven by increasing investments in stem cell research and regenerative medicine therapies. Major pharmaceutical companies are allocating significant resources to develop advanced cell-based treatments for chronic diseases.
Other TrendsAdvancements in Automated Harvesting Technology
Automated cell harvesters now represent over 65% of the market, replacing manual systems due to their superior efficiency and reduced contamination risks. Leading manufacturers like Sartorius and Terumo BCT are introducing AI-integrated systems that improve yield precision by 30-40% compared to traditional methods.
Regional Market DevelopmentsNorth America currently dominates with 42% market share, while the Asia-Pacific region shows the fastest growth (11.2% CAGR) due to expanding biotechnology infrastructure in China and India. Europe maintains strong demand with Germany and the UK leading in adoption of GMP-compliant harvesting systems for clinical applications.
Increasing Application in Stem Cell Therapies
Stem cell research applications account for 58% of cell harvesting system usage, particularly for oncology and neurology treatments. The rising prevalence of chronic diseases (expected to affect 57% of the global population by 2030) is creating sustained demand for reliable cell harvesting solutions.
Competitive Landscape EvolutionMajor players like PerkinElmer and GE Healthcare are focusing on strategic acquisitions, while startups are introducing innovative disposable harvesting solutions. The market remains moderately concentrated, with the top 5 companies holding 48% revenue share as of 2024.
Regional Analysis: Cell Harvesting System MarketEurope
Europe maintains strong market position with its centralized cell therapy infrastructure and harmonized regulatory framework. The region sees growing adoption of automated systems in clinical settings, particularly in Germany and the UK where cell therapy manufacturing facilities are expanding. Academic-hospital partnerships drive demand for research-grade harvesters capable of handling diverse cell types. Increasing focus on personalized medicine creates opportunities for small-scale, flexible harvesting systems alongside industrial-scale equipment. Strict EU regulations on cell processing encourage investment in closed, automated platforms that minimize manual intervention and contamination risks during harvesting procedures.
Asia-Pacific
The Asia-Pacific market demonstrates rapid growth fueled by biopharmaceutical expansion and government-backed stem cell initiatives. Countries like China and South Korea invest heavily in biotechnology parks equipped with advanced cell processing infrastructure. Price-sensitive markets drive demand for mid-range harvesting systems, while premium research centers adopt high-end automated solutions. Increasing clinical trials for cell therapies create new opportunities for harvesting system vendors. However, market penetration faces challenges related to technical training requirements and variability in regulatory standards across countries in the region.
South America
South America shows emerging potential with growing research activities in Brazil and Argentina. Public health systems gradually incorporate cell therapies, generating demand for reliable harvesting equipment. The market remains cost-conscious, favoring multi-purpose systems that serve both research and small-scale clinical applications. Limited local manufacturing capabilities create dependence on international suppliers, though regional distributors enhance equipment accessibility across major research hubs. Infrastructure limitations in some areas restrict adoption of sophisticated automated harvesting platforms.
Middle East & Africa
The MEA region experiences steady growth centered around medical tourism hubs and specialized treatment centers. Gulf countries invest in advanced cell therapy facilities that utilize automated harvesting technologies. South Africa leads in research applications while North African nations show increasing interest in therapeutic applications. Market growth confronts challenges from budget constraints and the need for specialized technical support. Emerging public-private partnerships aim to build local capacity in cell processing technologies through strategic equipment acquisitions and training programs.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical and biotech companies
Medical device and diagnostics manufacturers
Healthcare providers and hospital systems
Contract research and manufacturing organizations
Investors, consultants, and policy makers
-> Global cell harvesting system market was valued at USD 3,839 million in 2024 and is projected to reach USD 6,720 million by 2031.
Which key companies operate in Global Cell Harvesting System Market?
-> Key players include PerkinElmer, Terumo BCT, Tomtec, COX Scientific, and Sartorius, among others.
-> Key growth drivers include rising investments in regenerative medicine, growth of the biopharmaceutical industry, and increasing incidence of chronic diseases.
-> North America is the dominant market with over 40% revenue share, while Asia-Pacific is the fastest-growing region.
-> Emerging trends include the shift towards automated harvesters and advancements in stem cell harvesting for regenerative therapies.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates